About this trial
This study aims to compare the effects of genotype-based dietary counseling with standard dietary counseling based on general recommendations on weight loss and reduction of body fat. Participants will receive individualized dietary guidance either informed by genetic information or based on conventional dietary guidelines. Changes in body weight and body composition will be assessed over the course of the intervention.
Eligibility criteria
Qualifiers
Adults aged ≥18 years
Body mass index (BMI) ≥25 kg/m²
Greek-speaking (able to read and understand Greek and provide informed consent)
Willing and able to participate in dietary counseling and study assessments for the duration of the study
Disqualifiers
Current use of pharmacological treatments for weight loss, including but not limited to GLP-1 receptor agonists, appetite suppressants, or other anti-obesity medications
Participation in any structured weight-loss intervention or program within the previous 3 months, including commercial weight-loss programs or medically supervised dietary interventions
Use of medications known to significantly affect body weight or body composition, such as systemic corticosteroids, antipsychotic medications, or medications for thyroid disorders
Pregnancy or lactation
Trial design
Treatments tested in this trial
- Genotype-Based Dietary Counseling
- Standard Dietary Counseling